Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

CLI Analysis: Majority of Operation Warp Speed Vaccines Not Produced Using Abortion-Derived Cells

FOR IMMEDIATE RELEASE: December 3, 2020

Contact: Prudence Robertson, [email protected], 240-672-2828

 

Several Used Abortion-Derived Cell Lines in Testing; Experts Urge All Vaccine Developers to Use Noncontroversial Alternatives


Washington, D.C.
  – Today Charlotte Lozier Institute (CLI) published a new chart detailing whether the eight leading COVID-19 vaccine candidates supported by Operation Warp Speed are produced or tested using cells derived from abortions. The vaccine candidates evaluated are those produced by Pfizer/BioNTech, Moderna, AstraZeneca, Johnson & Johnson, Novavax, Sanofi/GSK, Inovio, and Merck.

 

CLI’s analysis found that a majority of vaccine candidates did not use abortion-derived cell lines in their production. Several used abortion-derived cell lines in laboratory testing, or their use in testing could not be determined.

 

CLI offered the following additional statement:

 

“CLI’s expert scientific analysis finds that many leading vaccine candidates supported by Operation Warp Speed do not use abortion-derived cell lines in their production. This is encouraging news.

 

“Unfortunately, some vaccine developers have unnecessarily put American families in a difficult position by choosing to use controversial human fetal cell lines in production or testing, or by a lack of transparency. Many developers already opt to use animal cell lines, non-fetal human cells, yeast, or chicken eggs instead. We urge all developers to avail themselves of these options going forward. Doing so will reduce vaccine hesitancy for those who oppose the use of fetal cell lines, thereby increasing the public health impact of the vaccine.

 

“It remains to be seen which vaccines will be approved for emergency use and how soon they will be available to patients. CLI will continue to provide the public with access to timely and accurate information so that individuals and families can weigh all factors – including secular science and religious traditions – and make vaccine decisions in line with their conscience.”

 

CLI Vice President Dr. David Prentice, and Director of Life Sciences Dr. Tara Sander Lee are available to discuss with media. To request an interview, please contact Prudence Robertson at [email protected] or 240-672-2828.

 

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

 

The information, including but not limited to, text, graphics, images and other material contained on this website are for educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

 

Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony List. CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The Institute is named for a feminist physician known for her commitment to the sanctity of human life and equal career and educational opportunities for women.  The 175th anniversary of Dr. Charlotte Denman Lozier’s birth occurred on March 16, 2019.

###

 

Latest Posts

May 13, 2024 New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs May 9, 2024 Abortion Reporting: Oklahoma (2023) April 30, 2024 Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)

You Might Also Be Interested In

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

April 22, 2024
ClosePlease login
Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image